TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy

Nature Reviews Endocrinology

Volumn 11, Issue 3, 2015, Pages 171-181

  Smith, Terry J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; HYALURONIC ACID; SOMATOMEDIN C; THYROGLOBULIN; THYROTROPIN RECEPTOR; CD34 ANTIGEN;

ADIPOGENESIS; B LYMPHOCYTE; CD34 FIBROBLAST; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELLS BY BODY ANATOMY; CONNECTIVE TISSUE; CYTOKINE PRODUCTION; ENDOCRINE OPHTHALMOPATHY; FIBROBLAST; FIBROCYTE; MYOFIBROBLAST; ORBIT; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; THYROID GLAND; ANIMAL; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD34; FIBROBLASTS; GRAVES OPHTHALMOPATHY; HUMANS; INFLAMMATION; INSULIN-LIKE GROWTH FACTOR I; RECEPTORS, THYROTROPIN; SIGNAL TRANSDUCTION;

EID: 84923700329     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2014.226     Document Type: Review

References (124)

1. Brent, G. A. Graves' disease. N. Engl. J. Med. 358, 2594-2605 (2008
2. Bahn, R. S. Graves' ophthalmopathy. N. Engl. J. Med. 362, 726-738 (2010
3. Rundle, F. F. & Wilson, C. W. Development and course of exophthalmos and ophthalmoplegia in Graves' disease with special reference to the effect of thyroidectomy. Clin. Sci. 5, 177-194 (1945
4. Smith, T. J., Bahn, R. S. & Gorman, C. A. Connective tissue, glycosaminoglycans, and diseases of the thyroid. Endocr. Rev. 10, 366-391 (1989
5. Smith, T. J., et al. Unique attributes of orbital fibroblasts and global alterations in IGF 1 receptor signaling could explain thyroid-Associated ophthalmopathy. Thyroid 18, 983-988 (2008
6. Tani, J., Gopinath, B., Nguyen, B. & Wall, J. R. Extraocular muscle autoimmunity and orbital flat inflammation in thyroid-Associated ophthalmopathy. Expert Rev. Clin. Immunol. 3, 299-311 (2007
7. Wang, Y. & Smith, T. J. Current concepts in the molecular pathogenesis of thyroid-Associated ophthalmopathy. Invest. Ophthalmol. 55, 1735-1748 (2014
8. Lantz, M., et al. Overexpression of immediate early genes in active Graves' ophthalmopathy. J. Clin. Endocrinol. Metab. 90, 4784-4791 (2005
9. Vondrichova, T., et al. COX 2 and SCD, markers of inflammation and adipogenesis, are related to disease activity in Graves' ophthalmopathy. Thyroid 17, 511-517 (2007
10. Douglas, R. S., et al. Increased generation of fibrocytes in thyroid-Associated ophthalmopathy. J. Clin. Endocrinol. Metab. 95, 430-438 (2010
11. Parmentier, M., et al. Molecular cloning of the thyrotropin receptor. Science 246, 1620-1622 (1989
12. Davies, T. F., Ando, T., Lin, R. Y. & Latif, R. Thyrotropin receptor-Associated diseases: from adenomata to Graves disease. J. Clin. Invest. 115, 1972-1983 (2005
13. Allgeier, A., et al. The human thyrotropin receptor activates G proteins Gs and Gq/11. J. Biol. Chem. 269, 13733-13735 (1994
14. Fuse, M., et al. Regulation of geranylgeranyl pyrophosphate synthase in the proliferation of rat FRTL 5 cells: involvement of both cAMP-PKA and PI3-AKT pathways. Biochem. Biophys. Res. Commun. 315, 1147-1153 (2004
15. Hara, T., et al. Thyrotropin regulates c Jun N terminal kinase (JNK) activity through two distinct signal pathways in human thyroid cells. Endocrinology 140, 1724-1730 (1999
16. Zaballos, M. A., Garcia, B. & Santisteban, P. Gβγ dimers released in response to thyrotropin activate phosphoinositide 3 kinase and regulate gene expression in thyroid cells. Mol. Endocrinol. 22, 1183-1199 (2008
17. Saunier, B., Tournier, C., Jacquemin, C. & Pierre, M. Stimulation of mitogen-Activated protein kinase by thyrotropin in primary cultured human thyroid follicles. J. Biol. Chem. 270, 3693-3697 (1995
18. Suh, J. M., et al. Regulation of the phosphatidylinositol 3 kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland. J. Biol. Chem. 278, 21960-21971 (2003
19. Morshed, S. A., Latif, R. & Davies, T. F. Characterization of thyrotropin receptor antibody-induced signaling cascades. Endocrinology 150, 519-529 (2009
20. Smith, B. R., Sanders, J. & Furmaniak, J. TSH receptor antibodies. Thyroid 17, 923-938 (2007
21. Feliciello, A., et al. Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet 342, 337-338 (1993
22. Gerding, M. N., et al. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin. Endocrinol. (Oxf.) 52, 267-271 (2000
23. Lytton, S. D., et al. A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy. J. Clin. Endocrinol. Metab. 95, 2123-2131 (2010
24. Ponto, K. A., et al. Clinical relevance of thyroid-stimulating immunoglobulins in Graves' ophthalmopathy. Ophthalmology 118, 2279-2285 (2011
25. Diana, T., et al. Clinical relevance of thyroid-stimulating autoantibodies in pediatric Graves' disease-A multicenter study. J. Clin. Endocrinol. Metab. 99, 1648-1655 (2014
26. Heufelder, A. E. & Bahn, R. S. Evidence for the presence of a functional TSH-receptor in retroocular fibroblasts from patients with Graves' ophthalmopathy. Exp. Clin. Endocrinol. 100, 62-67 (1992
27. Valyasevi, R. W., et al. Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. J. Clin. Endocrinol. Metab. 84, 2557-2562 (1999
28. Slominski, A., et al. Expression of hypothalamic-pituitary-Thyroid axis related genes in the human skin. J. Invest. Dermatol. 119, 1149-1455 (2002
29. Shimura, H., Miyazaki, A., Haraguchi, K., Endo, T. & Onaya, T. Analysis of differentiation-induced expression mechanisms of thyrotropin receptor gene in adipocytes. Mol. Endocrinol. 12, 1473-1486 (1998
30. Bell, A., et al. Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts. Am. J. Physiol. Cell Physiol. 279, C335-C340 (2000
31. Cianfarani, F., et al. TSH receptor and thyroid-specific gene expression in human skin. J. Invest. Dermatol. 130, 93-101 (2010
32. Endo, T., Ohta, K., Haraguchi, K. & Onaya, T. Cloning and functional expression of a thyrotropin receptor cDNA from rat fat cells. J. Biol. Chem. 270, 10833-10837 (1995
33. Raychaudhuri, N., Fernando, R. & Smith, T. J. Thyrotropin regulates IL 6 expression in CD34+ fibrocytes: clear delineation of its cAMP-independent actions. PLoS ONE 8, E75100 (2013
34. Rotella, C. M., Zonefrati, R., Toccafondi, R., Valente, W. A. & Kohn, L. D. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. J. Clin. Endocrinol. Metab. 62, 357-367 (1986
35. Kumar, S., Schiefer, R., Coenen, M. J. & Bahn, R. S. A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin 6 expression and secretion in Graves' orbital preadipocyte fibroblasts. Thyroid 20, 59-65 (2010
36. Zhang, L., et al. Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction. J. Biol. Chem. 284, 26447-26455 (2009
37. Kumar, S., Iyer, S., Bauer, H., Coenen, M. & Bahn, R. S. A stimulatory thyrotropin receptor antibody enhances hyaluronic acid synthesis in graves' orbital fibroblasts: inhibition by an IGF I receptor blocking antibody. J. Clin. Endocrinol. Metab. 97, 1681-1687 (2012
38. Pappa, A., et al. Analysis of extraocular muscle infiltrating T cells in thyroid-Associated ophthalmopathy (TAO). Clin. Exp. Immunol. 109, 362-369 (1997
39. Grubeck-Loebenstein, B., et al. Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts. J. Clin. Invest. 93, 2738-2743 (1994
40. Ecksteink, A. K., et al. Thyroid associated ophthalmopathy: evidence for CD4+ γd T cells; de novo differentiation of RFD7+ macrophages, but not of RFD1+ dendritic cells; and loss of γd and aβ T cell receptor expression. Br. J. Ophthalmol. 88, 803-808 (2004
41. de Carli, M., et al. Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy. J. Clin. Endocrinol. Metab. 77, 1120-1124 (1993
42. Sciaky, D., Brazer, W., Center, D. M., Cruikshank, W. W. & Smith T. J. Cultured human fibroblasts express constitutive IL 16 mRNA: cytokine induction of active IL 16 protein synthesis through a caspase 3 dependent mechanism. J. Immunol. 164, 3806-3814 (2000
43. Hwang, C. J., et al. Orbital fibroblasts from patients with thyroid-Associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL 6, IL 8, and MCP 1. Invest. Ophthalmol. Vis. Sci. 50, 2262-2268 (2009
44. Antonelli, A., et al. (CCL2) anda (CXCL10) chemokine modulations by cytokines and peroxisome proliferator-Activated receptor á agonists in Graves' ophthalmopathy. J. Endocrinol. 213, 183-191 (2012
45. Weightman, D. R., Perros, P., Sherif, I. H. & Kendall-Taylor, P. Autoantibodies to IGF 1 binding sites in thyroid associated ophthalmopathy. Autoimmunity 16, 251-257 (1993
46. Smith, T. J. Insulin-like growth factor I regulation of immune function: a potential therapeutic target in autoimmune diseases?. Pharmacol. Rev. 62, 199-236 (2010
47. Pritchard, J., Horst, N., Cruikshank, W. & Smith, T. J. Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts. J. Immunol. 168, 942-950 (2002
48. Pritchard, J., Han, R., Horst, N., Cruikshank, W. W. & Smith, T. J. Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the IGF 1 receptor pathway. J. Immunol. 170, 6348-6354 (2003
49. Varewijck, A. J., et al. Circulating IgGs may modulate IGF I receptor stimulating activity in a subset of patients with Graves' ophthalmopathy. J. Clin. Endocrinol. Metab. 98, 769-776 (2013
50. Minich, W. B., et al. Autoantibodies to the IGF1 receptor in Graves' orbitopathy. J. Clin. Endocrinol. Metab. 98, 752-760 (2013
51. Smith, T. J. Is IGF I receptor a target for autoantibody generation in Graves' disease?. J. Clin. Endocrinol. Metab. 98, 515-518 (2013
52. Douglas, R. S., Gianoukakis, A. G., Kamat, S. & Smith, T. J. Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis. J. Immunol. 178, 3281-3287 (2007
53. Douglas, R. S., et al. B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis. J. Immunol. 181, 5768-5774 (2008
54. Tramontano, D., Cushing, G. W., Moses, A. C. & Ingbar, S. H. Insulin-like growth factor I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves'-IgG. Endocrinology 119, 940-942 (1986
55. Garcia, B. & Santisteban, P. PI3K is involved in the IGF I inhibition of TSH-induced sodium/iodide symporter gene expression. Mol. Endocrinol. 16, 342-352 (2002
56. Brenner-Gati, L., Berg, K. A. & Gershengorn, M. C. Insulin-like growth factor I potentiates thyrotropin stimulation of adenylyl cyclase in FRTL 5 cells. Endocrinology 125, 1315-1320 (1989
57. Sastre-Perona, A. & Santisteban, P. Wnt-independent role of β catenin in thyroid cell proliferation and differentiation. Mol. Endocrinol. 28, 681-695 (2014
58. Ock, S., et al. IGF 1 receptor deficiency in thyrocytes impairs thyroid hormone secretion and completely inhibits TSH-stimulated goiter. FASEB J. 27, 4899-4908 (2013
59. Clement, S., Refetoff, S., Robaye, B., Dumont, J. E. & Schurmans, S. Low TSH requirement and goiter in transgenic mice overexpressing IGF I and IGF-Ir receptor in the thyroid gland. Endocrinology 142, 5131-5139 (2001
60. Tsui, S., et al. Evidence for an association between thyroid stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease. J. Immunol. 181, 4397-4405 (2008
61. Wiersinga, W. M. Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF 1 receptors?. J. Clin. Endocrinol. Metab. 96, 2386-2394 (2011
62. Kriss, J. P. Radioisotopic thyroidolymphography in patients with Graves' disease. J. Clin. Endocrinol. Metab. 31, 315-323 (1970
63. Tao, T. W. Cheng, P. J. Pham, H. Leu, S. L. & Kriss, J. P. Monoclonal antithyroglobulin antibodies derived from immunizations of mice with human eye muscle and thyroid membranes. J. Clin. Endocrinol. Metab. 63, 577-582 (1986
64. Marinò, M., et al. Identification of thyroglobulin in orbital tissues of patients with thyroid-Associated ophthalmopathy. Thyroid 11, 177-185 (2001
65. Marinò, M., et al. Glycosaminoglycans provide a binding site for thyroglobulin in orbital tissues of patients with thyroid-Associated ophthalmopathy. Thyroid 13, 851-859 (2003
66. Lisi, S., et al. Thyroglobulin in orbital tissues from patients with thyroid-Associated ophthalmopathy: predominant localization in fibroadipose tissue. Thyroid 12, 351-360 (2002
67. Young, D. A., Evans, C. H. & Smith, T. J. Leukoregulin induction of protein expression in human orbital fibroblasts: evidence for anatomical site-restricted cytokine-Target cell interactions. Proc. Natl Acad. Sci. USA 95, 8904-8909 (1998
68. Meyer zu Hörste, M., et al. A novel mechanism involved in the pathogenesis of Graves ophthalmopathy (GO): clathrin is a possible targeting molecule for inhibiting local immune response in the orbit. J. Clin. Endocrinol. Metab. 96, E1727-E1736 (2011
69. van Steensel, L., et al. Orbit-infiltrating mast cells, monocytes, and macrophages produce PDGF isoforms that orchestrate orbital fibroblast activation in Graves' ophthalmopathy. J. Clin. Endocrinol. Metab. 97, E400-E408 (2012
70. van Steensel, L., et al. Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves' ophthalmopathy. Invest. Ophthalmol. Vis. Sci. 51, 1002-1007 (2010
71. Hwang, C. J., et al. Orbital fibroblasts from patients with thyroid-Associated ophthalmopathy overexpress CD4: CD154 hyperinduces IL 6, IL 8, and MCP 1. Invest. Ophthalmol. Vis. Sci. 50, 2262-2268 (2009
72. Raychaudhuri, N., Douglas, R. S. & Smith, T. J. PGE2 induces IL 6 in orbital fibroblasts through EP2 receptors and increased gene promoter activity: implications to thyroid-Associated ophthalmopathy. PLoS ONE 5, E15296 (2010
73. Chen, B., et al. IL 4 induces 15 lipoxygenase 1 expression in human orbital fibroblasts from patients with Graves' disease: evidence for anatomic site-selective action of Th2 cytokines. J. Biol. Chem. 281, 18296-18306 (2006
74. Han, R., Tsui, S. & Smith, T. J. Up-regulation of prostaglandin E2 synthesis by interleukin 1β in human orbital fibroblasts involves coordinate induction of prostaglandin-endoperoxide H synthase 2 and glutathione-dependent prostaglandin E2 synthase expression. J. Biol. Chem. 277, 16355-16364 (2002
75. Li, B. & Smith, T. J. Divergent expression of IL 1 receptor antagonists in CD34+ fibrocytes and orbital fibroblasts in thyroid-Associated ophthalmopathy: contribution of fibrocytes to orbital inflammation. J. Clin. Endocrinol. Metab. 98, 2783-2790 (2013
76. Gabay, C., Lamacchia, C. & Palmer, G. IL 1 pathways in inflammation and human diseases. Nat. Rev. Rheumatol. 6, 232-241 (2010
77. Watson, J. M., et al. The intracellular IL 1 receptor antagonist alters IL 1 inducible gene expression without blocking exogenous signaling by IL 1 β. J. Immunol. 155, 4467-4475 (1995
78. Li, B. & Smith, T. J. Regulation of IL 1 receptor antagonist by TSH in fibrocytes and orbital fibroblasts. J. Clin. Endocrinol. Metab. 99, E625-E633 (2014
79. Li, B. & Smith, T. J. PI3K/AKT pathway mediates induction of IL 1RA by TSH in fibrocytes: modulation by PTEN. J. Clin. Endocrinol. Metab. 99, 3363-3372 (2014
80. Spicer, A. P., Kaback, L. A., Smith, T. J. & Seldin, M. F. Molecular cloning and characterization of the human and mouse UDP glucose dehydrogenase genes. J. Biol. Chem. 273, 25117-25124 (1998
81. Tsui, S., Fernando, R., Chen, B. & Smith, T. J. Divergent Sp1 levels may underlie differential expression of UDP glucose dehydrogenase by fibroblasts: role in susceptibility to orbital Graves' disease. J. Biol. Chem. 286, 24487-24499 (2011
82. Kaback, L. A. & Smith, T. J. Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1β in human orbital fibroblasts: potential insight into the molecular pathogenesis of thyroid-Associated ophthalmopathy. J. Clin. Endocrinol. Metab. 84, 4079-4084 (1999
83. Guo, N., Woeller, C., F., Feldon, S. E. & Phipps, R. P. Peroxisome proliferator-Activated receptor γ ligands inhibit transforming growth factor β-induced, hyaluronan-dependent, T cell adhesion to orbital fibroblasts. J. Biol. Chem. 286, 18856-18867 (2011
84. Smith, T. J., Wang, H. S. & Evans, C. H. Leukoregulin is a potent inducer of hyaluronan synthesis in cultured human orbital fibroblasts. Am. J. Physiol. 268, C382-C388 (1995
85. Guo, N., Baglole, C. J., O'Loughlin, C. W., Feldon, S. E. & Phipps, R. P. Mast cell-derived prostaglandin D2 controls hyaluronan synthesis in human orbital fibroblasts via DP1 activation: implications for thyroid eye disease. J. Biol. Chem. 285, 15794-15804 (2010
86. Cao, H. J., et al. Activation of human orbital fibroblasts through CD40 engagement results in a dramatic induction of hyaluronan synthesis and prostaglandin endoperoxide H synthase 2 expression: insights into potential pathogenic mechanisms of thyroid associated ophthalmopathy. J. Biol. Chem. 273, 29615-29625 (1998
87. Smith, T. J. & Hoa, N. Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-Antigen, IGF 1 receptor. J. Clin. Endocrinol. Metab. 89, 5076-5080 (2004
88. Jackson, D. G. Immunological functions of hyaluronan and its receptors in the lymphatics. Immunol. Rev. 230, 216-231 (2009
89. Noden, D. M. The role of the neural crest in patterning of avian cranial skeletal, connective, and muscle tissues. Dev. Biol. 96, 144-165 (1983
90. Smith, T. J., et al. Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts. J. Clin. Endocrinol. Metab. 80, 2620-2625 (1995
91. Smith, T. J., et al. Prostaglandin E2 elicits a morphological change in cultured orbital fibroblasts from patients with Graves ophthalmopathy. Proc. Natl Acad. Sci. USA 91, 5094-5098 (1994
92. Henrikson, R. C. & Smith, T. J. Ultrastructure of cultured human orbital fibroblasts. Cell Tissue Res. 278, 629-631 (1994
93. Koumas, L., Smith, T. J. & Phipps, R. P. Fibroblast subsets in the human orbit: Thy 1+ and Thy 1- subpopulations exhibit distinct phenotypes. Eur. J. Immunol. 32, 477-485 (2002
94. Sorisky, A., Pardasani, D., Gagnon, A. & Smith, T. J. Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture. J. Clin. Endocrinol. Metab. 81, 3428-3431 (1996
95. Koumas, L., Smith, T. J., Feldon, S., Blumberg, N. & Phipps, R. P. Thy 1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am. J. Pathol. 163, 1291-1300 (2003
96. Smith, T. J., et al. Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-Associated ophthalmopathy. J. Clin. Endocrinol. Metab. 87, 385-392 (2002
97. Li, H., et al. Independent adipogenic and contractile properties of fibroblasts in Graves' orbitopathy: an in vitro model for the evaluation of treatments. PLoS ONE 9, e95586 (2014
98. Lehmann, G. M., et al. Novel anti-Adipogenic activity produced by human fibroblasts. Am. J. Physiol. Cell Physiol. 299, C672-C681 (2010
99. Bucala, R., Spiegel, L. A., Chesney, J., Hogan, M. & Cerami, A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol. Med. 1, 71-81 (1994
100. Chesney, J., Metz, C., Stavitsky, A. B., Bacher, M. & Bucala, R. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J. Immunol. 160, 419-425 (1998
101. Yang, L., et al. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab. Invest. 82, 1183-1192 (2002
102. Bohle, A., et al. Pathogenesis of chronic renal failure in primary glomerulopathies. Nephrol. Dial. Transplant. 9 (Suppl 3), 4-12 (1994
103. Scholten, D., et al. Migration of fibrocytes in fibrogenic liver injury. Am. J. Pathol. 179, 189-198 (2011
104. Wang, C. H., et al. Increased circulating fibrocytes in asthma with chronic airflow obstruction. Am. J. Respir. Crit. Care Med. 178, 583-591 (2008
105. Galligan, C. L., et al. Fibrocyte activation in rheumatoid arthritis. Rheumatology (Oxford) 49, 640-651 (2010
106. Pilling, D., Fan, T., Huang, D., Kaul, B. & Gomer, R. H. Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS ONE 4, e7475 (2009
107. Hong, K. M., Belperio, J. A., Keane, M. P., Burdick, M. D. & Strieter, R. M. Differentiation of human circulating fibrocytes as mediated by transforming growth factor β and peroxisome proliferator-Activated receptor γ. J. Biol. Chem. 282, 22910-22920 (2007
108. Chesney, J., Bacher, M., Bender, A. & Bucala, R. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc. Natl Acad. Sci. USA 94, 9307-6312 (1997
109. Abe, R., Donnelly, S. C., Peng, T., Bucala, R. & Metz, C. N. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J. Immunol. 166, 7556-7562 (2001
110. Moeller, A., et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 179, 588-594 (2009
111. Wang, J. F., et al. Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Repair Regen. 15, 113-121 (2007
112. Phillips, R. J., et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J. Clin. Invest. 114, 438-446 (2004
113. Kazim, M., Goldberg, R. A. & Smith, T. J. Insights into the pathogenesis of thyroid-Associated orbitopathy: evolving rationale for therapy. Arch. Ophthalmol. 120, 380-386 (2002
114. Gillespie, E. F., et al. Increased expression of TSH receptor by fibrocytes in thyroid-Associated ophthalmopathy leads to chemokine production. J. Clin. Endocrinol. Metab. 97, E740-E746 (2012
115. Fernando, R., et al. Human fibrocytes coexpress thyroglobulin and thyrotropin receptor. Proc. Natl Acad. Sci. USA 109, 7427-7432 (2012
116. Fernando, R., et al. Expression of thyrotropin receptor, thyroglobulin, sodium-iodide symporter, and thyroperoxidase by fibrocytes depends on AIRE. J. Clin. Endocrinol. Metab. 99, E1236-E1244 (2014
117. Nagamine, K., et al. Positional cloning of the APECED gene. Nat. Genet. 17, 393-398 (1997
118. Fernando, R., et al. Human fibrocytes express multiple antigens associated with autoimmune endocrine diseases. J. Clin. Endocrinol. Metab. 99, E796-E803 (2014
119. Neumann, S., et al. A selective TSH receptor antagonist inhibits stimulation of thyroid function in female mice. Endocrinology 155, 310-314 (2014
120. Sanders, P., et al. Crystal structure of the TSH receptor (TSHR) bound to a blocking-Type TSHR autoantibody. J. Mol. Endocrinol. 46, 81-99 (2011
121. Sanders, P., et al. Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function. Thyroid 14, 560-570 (2004
122. Núñez Miguel, R., et al. Similarities and differences in interactions of thyroid stimulating and blocking autoantibodies with the TSH receptor. J. Mol. Endocrinol. 49, 137-151 (2012
123. Chen, H., et al. Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF 1 action in fibrocytes. J. Clin. Endocrinol. Metab. 99, E1635-E1640 (2014
124. US National Institutes of Health. ClinicalTrials.gov [online], http://clinicaltrials.gov/show/NCT01868997 (2014